Finance

Lists
Why is 207940 down २.५२%?
Dive Deeper
207940:KRX
Samsung Biologics Co Ltd
₩ १३,९१,०००.००
-२.५२%
(-३६,०००.००) 1D
अक्टोबर २०, १५:३०:२५ GMT+९  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 207940...
Open
₩ १४,२०,०००
High
₩ १४,४०,०००
Low
₩ १३,७०,०००
Mkt. cap
६.७५ शंख
Avg. vol.
५३.१२ हजार
Volume
९२.९६ हजार
P/E ratio
३०.३१
52-wk high
₩ १९,७३,६००
52-wk low
₩ ११,१०,४६०
EPS
₩ ४५,८९७
Shares outstanding
४.६३ करोड
No. of employees
५ हजार
Open
₩ १४,२०,०००
High
₩ १४,४०,०००
Low
₩ १३,७०,०००
Mkt. cap
६.७५ शंख
Avg. vol.
५३.१२ हजार
Volume
९२.९६ हजार
P/E ratio
३०.३१
52-wk high
₩ १९,७३,६००
52-wk low
₩ ११,१०,४६०
EPS
₩ ४५,८९७
Shares outstanding
४.६३ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines. The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
CEOJohn Rim
Employees५.३३ हजार
Founded२०११
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१६.६० खरब
१२.८६ खरब
१२.५७ खरब
१३.२१ खरब
Cost of goods sold
६.८५ खरब
६.१४ खरब
५.७८ खरब
६.२३ खरब
Cost of revenue
६.८५ खरब
६.१४ खरब
५.७८ खरब
६.२३ खरब
Research and development expenses
३४.२८ अरब
-
७.२४ अरब
९.०३ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९८ खरब
१.४४ खरब
८१.६८ अरब
८७.९० अरब
Operating expense
२.४६ खरब
१.४४ खरब
९८.०९ अरब
१.१२ खरब
Total operating expenses
९.३१ खरब
७.५८ खरब
६.७६ खरब
७.३४ खरब
Operating income
७.२९ खरब
५.२८ खरब
५.८१ खरब
५.८६ खरब
Other non operating income
४.५४ अरब
४७.०० अरब
२.४४ अरब
८.०० अरब
EBT including unusual items
७.६७ खरब
५.७५ खरब
६.४१ खरब
५.८५ खरब
EBT excluding unusual items
७.६७ खरब
५.७५ खरब
६.४१ खरब
५.८५ खरब
Income tax expense
१.९३ खरब
१.२२ खरब
१.७१ खरब
१.५४ खरब
Effective tax rate
२५.१०%
२१.२२%
२६.७५%
२६.३४%
Other operating expenses
५९.८० करोड
-
५७.८३ करोड
५.६८ अरब
Net income
५.७४ खरब
५.१० खरब
४.६९ खरब
४.३१ खरब
Net profit margin
३४.६०%
३९.६६%
३७.३३%
३२.६०%
Earnings per share
८.०७ हजार
८.७२ हजार
१०.१५ हजार
९.३१ हजार
Interest and investment income
१३.३५ अरब
-
१३.९७ अरब
१३.२९ अरब
Interest expense
-१०.७१ अरब
-
-७.१५ अरब
-८.७८ अरब
Net interest expenses
२.६४ अरब
-
६.८३ अरब
४.५१ अरब
Depreciation and amortization charges
८.८४ अरब
-
५.०७ अरब
५.२६ अरब
EBITDA
९.०८ खरब
-
६.७५ खरब
६.९९ खरब
Gain or loss from assets sale
४१.२६ करोड
-
१८.०० हजार
६७.६५ करोड
AI content may include mistakes. Learn more
Google एपहरू